EGF and breast cancer: Underscoring its significance in mammary carcinogenesis, EGF is present in several human breast cancer cell lines and in 15-30% of human primary invasive breast carcinomas; its mRNA is elevated in ERα-positive human breast cancer cell lines and tumors, and its expression correlates with poor prognosis in breast cancer patients [1].